Nanoparticle compositions for sustained therapy
US10485882B2 · kind B2 · utility
5Cited by
37References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 10, 2016 |
| Grant date | Nov 26, 2019 |
| Priority date | — |
| Expiry date | Nov 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides compositions and methods for promoting the formation, expansion and recruitment of TR1 cells and/or B cells in an antigen-specific manner and treating diseases and disorders in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.